Chemistry:IDNNA

IDNNA

Names
Preferred IUPAC name 1-(4-Iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(α-methyl)amine
Identifiers
CAS Number	85563-10-6 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL11043 Y
ChemSpider	119009 Y
PubChem CID	135056
UNII	M6Q9NK9RFD Y
InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Y Key: XBCUSBRGRALQID-UHFFFAOYSA-N Y InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYAY
SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C
Properties
Chemical formula	C13H20NO2I
Molar mass	349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is YN ?)
Infobox references

Tracking categories (test):

• SizeSet

IDNNA (2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 2.6 mg, and the duration unknown. IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants